ArticleBMC infectious diseases2025
Prevalence of hepatitis B virus and associated factors among blood donors in Hossana blood bank catchment area, Southern Ethiopia.
Article in BMC infectious diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Prevalence and Predictors of Hepatitis B Virus Infection Among Sellers and Workers at West Africa's Largest Market, Kejetia, Ghana: A Cross-Sectional Study.BioMed research international · 2026Article
- Epidemiological Profile and Diagnostic Outcomes of Blood Donors Following Hepatitis B Screening at the Largest Blood Bank in the State of Pará, Brazil.Infectious disease reports · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundHuman hepatitis is an inflammation of the liver brought on by the DNA virus known as the hepatitis B virus (HBV). Around the world, 240 million people are thought to have HBV in a chronic state. The prevalence of viral hepatitis is extremely high in Africa. Prior reports from various regions of the nation have indicated a variable prevalence of HBV infection.
objectiveTo estimate the prevalence of HBV infections and associated factors among blood donors in the Hossana blood bank catchment area in August 2023.
methodsA community-based cross-sectional study design was conducted among 546 blood donors in the Hossana blood bank catchment area from August 22 to September 22, 2023. Study participants were included using the system established by the blood bank. Both Binary and multivariable logistic regression analysis was conducted. The association of variables was declared at p-value < 0.05 and strength of association was presented using AOR with a corresponding 95% CI. The adequacy of the model was checked by Hosmer-Lemeshow test.
resultsa total of 546 participant's data was analyzed. The prevalence of HBV among blood donors in the Hossana blood bank catchment area was 7.88 with 95% CI [5.76-10.46]. No participants received post-donation counseling. Having multiple sexual partners (AOR = 5.18, 95% CI: 1.32-20.36), Sharing of sharp material (AOR = 3.66, 95% CI: 1.32-10.13) and tooth extraction (AOR = 5.55, 95% CI: 2.08-14.78) were identified as factors associated with HBV positivity.
conclusionIn this study, the prevalence of hepatitis B virus was 7.88, which is intermediate. Multiple sexual partners, sharing of sharp material, and tooth extraction were related to the hepatitis b virus. Though post-donation counseling is important for the control and prevention of hepatitis b virus infection, it has been neglected since the establishment of the blood bank we strongly recommend counseling regular donors. CLINICAL TRIAL NUMBER: Not applicable.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.